Valuation : West Pharmaceutical Services, Inc.

Market Cap 24.36B 20.91B 19.57B 17.92B 33.76B 2,326B 33.86B 232B 90.61B 1,172B 91.45B 89.47B 3,880B P/E 2026 *
40.4x
P/E 2027 * 35.1x
Enterprise Value 23.85B 20.48B 19.17B 17.55B 33.07B 2,278B 33.16B 227B 88.74B 1,148B 89.56B 87.62B 3,800B EV / Sales 2026 *
7.07x
EV / Sales 2027 * 6.5x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.28%
1 week-1.96%
Current month+0.47%
1 month+2.06%
3 months+10.76%
6 months+38.07%
Current year+28.39%
1 week 294.1
Extreme 294.1
306.6
1 month 289.05
Extreme 289.05
308.75
3 years 168.65
Extreme 168.65
386.1
5 years 168.65
Extreme 168.65
418.6
Manager TitleAgeSince
Chief Executive Officer 56 24/04/2015
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.96%+40.58%-18.31% 24.36B
-2.20%-2.23%-15.11%+7.08% 193B
-2.23%-2.52%-2.26%+9.47% 115B
-2.00%+2.08%+10.56%+78.98% 61.3B
-0.25%-3.97%+26.71%+53.11% 51.37B
-1.09%+0.27%-3.72%-32.81% 51.24B
+0.37%-1.03%+16.90%-11.38% 33.69B
+0.20%+6.35% - - 30.4B
-1.09%-2.17%+40.70%-12.10% 24.36B
-0.82%+2.71%-4.04%+18.23% 23.7B
Average -0.37%-0.18%+12.26%+10.25% 64.92B
Weighted average by Cap. +0.01%-1.05%+1.91%+13.23%

Financials

2026 *2027 *
Net sales 3.37B 2.9B 2.71B 2.48B 4.68B 322B 4.69B 32.11B 12.55B 162B 12.67B 12.4B 538B 3.59B 3.08B 2.88B 2.64B 4.97B 343B 4.99B 34.14B 13.34B 173B 13.47B 13.18B 571B
Net income 615M 528M 494M 452M 852M 58.69B 854M 5.85B 2.29B 29.58B 2.31B 2.26B 97.9B 701M 602M 564M 516M 972M 66.97B 975M 6.67B 2.61B 33.75B 2.63B 2.58B 112B
Net Debt -503M -432M -404M -370M -698M -48.07B -700M -4.79B -1.87B -24.22B -1.89B -1.85B -80.18B -1.04B -892M -835M -765M -1.44B -99.24B -1.44B -9.89B -3.87B -50.02B -3.9B -3.82B -166B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
-
Date Price Change
28/08/26 295.40 -0.74%
27/08/26 €297.60 -1.11%
26/08/26 €300.95 +0.67%
25/08/26 €298.95 -1.19%
24/08/26 €302.55 +0.03%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
346.09USD
Average target price
404.73USD
Spread / Average Target
+16.94%

Quarterly revenue - Rate of surprise